Table 1 Demographic and clinical characteristics of the hemodialysis patients
All population n = 73 | Hip pain in HD patients | P | ||
|---|---|---|---|---|
With hip pain n = 32 | Without hip pain n = 41 | |||
Age, years | 54.4 ± 11.3 | 54.0 ± 11.5 | 54.8 ± 11.2 | 0.771* |
Gender, n (%) | ||||
Female | 32 (43.8) | 18 (56.3) | 14 (34.1) | 0.095** |
Male | 41 (56.2) | 14 (43.8) | 27 (65.9) | |
BMI, kg/m2 | 26.0 ± 6.2 | 26.5 ± 7 | 25.6 ± 5.6 | 0.553* |
HD duration, years | 5 (0.5–30.0) | 9 (0.5–30) | 4 (0.5–24) | 0.171** |
< 10 years | 52 (71.2) | 18 (56.3) | 34 (82.9) | 0.019** |
> 10 years | 21 (28.8) | 14 (43.8) | 7 (17.1) | |
Co-morbidities | ||||
HT, n (%) | 33 (45.2) | 13 (40.6) | 20 (48.8) | 0.636** |
DM, n (%) | 18 (24.7) | 12 (37.5) | 6 (14.6) | 0.031** |
CD, n (%) | 12 (16.4) | 5 (15.6) | 7 (17.1) | 0.999** |
Laboratory parameters | ||||
Calcium (mg/dL) | 8.6 ± 0.8 | 8.5 ± 0.7 | 8.7 ± 1.0 | 0.414* |
Phosphate (mg/dL) | 5.2 ± 1.3 | 5.1 ± 1.1 | 5.3 ± 1.4 | 0.589* |
PTH (pg/mL) | 461 (1.5–2460) | 493.2 (1.5–2000) | 427 (8.5–2460) | 0.443* |
Vitamin D (ng/mL) | 13 (1.0–62.7) | 14.3 (3.5–49.2) | 12.7 (1–62.7) | 0.831* |
< 20 ng/mL | 54 (74.0) | 24 (75.0) | 30 (73.2) | 0.999* |
ALP (IU/mL) | 118 (39–950) | 140.5 (63–880) | 99 (39–950) | 0.059* |